Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. (Q44911263)

7 December 2017

Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. (English)

1 reference

7 December 2017

anti-retroviral agent

0 references

0 references

1 reference

8

1 reference

7 December 2017

7

Julio S G Montaner

1 reference

7 December 2017

4

Evan Wood

1 reference

7 December 2017

5

Kate Shannon

1 reference

7 December 2017

3

Benita Yip

1 reference

7 December 2017

2

Melanie L A Rusch

1 reference

7 December 2017

Sarah J Fielden

1

1 reference

PubMed ID

18812590

7 December 2017

Adrian R Levy

series ordinal

6

1 reference

7 December 2017

23 September 2008

1 reference

Journal of the International Association of Providers of AIDS Care

7 December 2017

1 reference

7 December 2017

7

1 reference

7 December 2017

5

1 reference

7 December 2017

238-244

1 reference

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

7 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Determinants of health-related quality of life in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Recent trends in HIV-related inpatient admissions 1996-2000: a 7-state study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Adherence to HAART Regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

A comparison study of multiple measures of adherence to HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Barriers to use of free antiretroviral therapy in injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Gender Differences in HIV-1 RNA Rebound Attributed to Incomplete Antiretroviral Adherence Among HIV-Infected Patients in a Population-Based Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Commercial sex work and STD: the need for policy interventions to change societal patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Determinants of HAART discontinuation among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109708323132

21 January 2018

Identifiers

DOI

10.1177/1545109708323132

1 reference

7 December 2017

1 reference

PubMed ID

18812590